BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 33130128)

  • 21. Distinct receptors and different transduction mechanisms for ATP and adenosine at the frog motor nerve endings.
    Sokolova E; Grishin S; Shakirzyanova A; Talantova M; Giniatullin R
    Eur J Neurosci; 2003 Sep; 18(5):1254-64. PubMed ID: 12956724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human rheumatoid synoviocytes express functional P2X7 receptors.
    Caporali F; Capecchi PL; Gamberucci A; Lazzerini PE; Pompella G; Natale M; Lorenzini S; Selvi E; Galeazzi M; Laghi Pasini F
    J Mol Med (Berl); 2008 Aug; 86(8):937-49. PubMed ID: 18545980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pharmacology of P2Y receptor subtypes.
    von Kügelgen I
    Biochem Pharmacol; 2021 May; 187():114361. PubMed ID: 33309519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials.
    da Silva Ferreira NC; Alves LA; Soares-Bezerra RJ
    Curr Drug Targets; 2019; 20(9):919-937. PubMed ID: 30760187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smooth muscle and purinergic contraction of the human, rabbit, rat, and mouse testicular capsule.
    Banks FC; Knight GE; Calvert RC; Turmaine M; Thompson CS; Mikhailidis DP; Morgan RJ; Burnstock G
    Biol Reprod; 2006 Mar; 74(3):473-80. PubMed ID: 16280417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P1-/P2-purinergic receptors on cultured rabbit retinal Müller cells.
    Liu Y; Wakakura M
    Jpn J Ophthalmol; 1998; 42(1):33-40. PubMed ID: 9507363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells.
    Seo DR; Kim SY; Kim KY; Lee HG; Moon JH; Lee JS; Lee SH; Kim SU; Lee YB
    Exp Mol Med; 2008 Feb; 40(1):19-26. PubMed ID: 18305394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nociceptive signaling mediated by P2X3, P2X4 and P2X7 receptors.
    Inoue K; Tsuda M
    Biochem Pharmacol; 2021 May; 187():114309. PubMed ID: 33130129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P2X receptors: Insights from the study of the domestic dog.
    Sluyter R; Sophocleous RA; Stokes L
    Neuropharmacology; 2023 Feb; 224():109358. PubMed ID: 36464207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P2 Receptors in Cardiac Myocyte Pathophysiology and Mechanotransduction.
    Woo SH; Trinh TN
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons.
    Tsuda M; Koizumi S; Kita A; Shigemoto Y; Ueno S; Inoue K
    J Neurosci; 2000 Aug; 20(15):RC90. PubMed ID: 10899177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of temporomandibular joint P2X3 and P2X2/3 receptors in carrageenan-induced inflammatory hyperalgesia in rats.
    Teixeira JM; Oliveira MC; Nociti FH; Clemente-Napimoga JT; Pelegrini-da-Silva A; Parada CA; Tambeli CH
    Eur J Pharmacol; 2010 Oct; 645(1-3):79-85. PubMed ID: 20558155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purinergic signaling in diabetes and metabolism.
    Jain S; Jacobson KA
    Biochem Pharmacol; 2021 May; 187():114393. PubMed ID: 33359363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomenclature and classification of purinoceptors.
    Fredholm BB; Abbracchio MP; Burnstock G; Daly JW; Harden TK; Jacobson KA; Leff P; Williams M
    Pharmacol Rev; 1994 Jun; 46(2):143-56. PubMed ID: 7938164
    [No Abstract]   [Full Text] [Related]  

  • 35. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
    Neary JT; McCarthy M; Kang Y; Zuniga S
    Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells.
    Yoshioka K; Saitoh O; Nakata H
    FEBS Lett; 2002 Jul; 523(1-3):147-51. PubMed ID: 12123822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The P2Y/P2X divide: How it began.
    Kennedy C
    Biochem Pharmacol; 2021 May; 187():114408. PubMed ID: 33444568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of P2X3 channel function by metabotropic P2Y2 utp receptors in primary sensory neurons.
    Mo G; Peleshok JC; Cao CQ; Ribeiro-da-Silva A; Séguéla P
    Mol Pharmacol; 2013 Mar; 83(3):640-7. PubMed ID: 23249537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
    Deb PK; Deka S; Borah P; Abed SN; Klotz KN
    Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
    von Kügelgen I; Stoffel D; Starke K
    Br J Pharmacol; 1995 May; 115(2):247-54. PubMed ID: 7670726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.